A BILL 
To amend the Internal Revenue Code of 1986 to provide 
for credits against tax for domestic medical and drug 
manufacturing and advanced medical manufacturing 
equipment. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘American Made Medi-
4
cine Act’’. 
5
03:03 Apr 08, 2022
H7410
2 
•HR 7410 IH
SEC. 2. DOMESTIC MEDICAL AND DRUG MANUFACTURING 
1
CREDIT. 
2
(a) IN GENERAL.—Subpart D of part IV of sub-
3
chapter A of chapter 1 of the Internal Revenue Code of 
4
1986 is amended by adding at the end the following new 
5
section: 
6
‘‘SEC. 45U. DOMESTIC MEDICAL AND DRUG MANUFAC-
7
TURING CREDIT. 
8
‘‘(a) IN GENERAL.—For purposes of section 38, the 
9
domestic medical and drug manufacturing credit deter-
10
mined under this section for any taxable year is an amount 
11
equal to 10.5 percent of the lesser of— 
12
‘‘(1) the qualified medical and drug manufac-
13
turing income of the taxpayer for the taxable year, 
14
or 
15
‘‘(2) taxable income of the taxpayer for the tax-
16
able year. 
17
‘‘(b) CREDIT LIMITED TO WAGES PAID.— 
18
‘‘(1) IN GENERAL.—The amount of the credit 
19
allowable under subsection (a) for any taxable year 
20
shall not exceed 50 percent of the W–2 wages of the 
21
taxpayer for the taxable year. 
22
‘‘(2) W–2 WAGES.—For purposes of this sec-
23
tion— 
24
‘‘(A) 
IN
GENERAL.—The 
term 
‘W–2 
25
wages’ means, with respect to any person for 
26
03:03 Apr 08, 2022
H7410
3 
•HR 7410 IH
any taxable year of such person, the sum of the 
1
amounts described in paragraphs (3) and (8) of 
2
section 6051(a) paid by such person with re-
3
spect to employment of employees by such per-
4
son during the calendar year ending during 
5
such taxable year. 
6
‘‘(B) LIMITATION
TO
WAGES
ATTRIB-
7
UTABLE
TO
DOMESTIC
PRODUCTION.—Such 
8
term shall not include any amount which is not 
9
properly allocable to domestic medical and drug 
10
manufacturing gross receipts for purposes of 
11
subsection (c)(1). 
12
‘‘(C) RETURN REQUIREMENT.—Such term 
13
shall not include any amount which is not prop-
14
erly included in a return filed with the Social 
15
Security Administration on or before the 60th 
16
day after the due date (including extensions) 
17
for such return. 
18
‘‘(3) ACQUISITIONS, DISPOSITIONS, AND SHORT 
19
TAXABLE YEARS.—The Secretary shall provide for 
20
the application of this subsection in cases of a short 
21
taxable year or where the taxpayer acquires, or dis-
22
poses of, the major portion of a trade or business or 
23
the major portion of a separate unit of a trade or 
24
business during the taxable year. 
25
03:03 Apr 08, 2022
H7410
4 
•HR 7410 IH
‘‘(c) QUALIFIED MEDICAL
AND DRUG MANUFAC-
1
TURING INCOME.—For purposes of this section— 
2
‘‘(1) IN GENERAL.—The term ‘qualified medical 
3
and drug manufacturing income’ for any taxable 
4
year means an amount equal to the excess (if any) 
5
of— 
6
‘‘(A) the taxpayer’s domestic medical and 
7
drug manufacturing gross receipts for the tax-
8
able year, over 
9
‘‘(B) the sum of— 
10
‘‘(i) the cost of goods sold that are al-
11
locable to such receipts, and 
12
‘‘(ii) other expenses, losses, or deduc-
13
tions which are properly allocable to such 
14
receipts. 
15
‘‘(2) ALLOCATION
METHOD.—The Secretary 
16
shall prescribe rules for the proper allocation of 
17
items described in paragraph (1)(B) for purposes of 
18
determining qualified medical and drug manufac-
19
turing income. Such rules shall provide for the prop-
20
er allocation of items whether or not such items are 
21
directly allocable to domestic medical and drug man-
22
ufacturing gross receipts. 
23
‘‘(3) 
SPECIAL
RULES
FOR
DETERMINING 
24
COSTS.— 
25
03:03 Apr 08, 2022
H7410
5 
•HR 7410 IH
‘‘(A) IN GENERAL.—For purposes of deter-
1
mining costs under clause (i) of paragraph 
2
(1)(B), any item or service brought into the 
3
United States shall be treated as acquired by 
4
purchase, and its cost shall be treated as not 
5
less than its value immediately after it entered 
6
the United States. 
7
‘‘(B) EXPORTS FOR FURTHER MANUFAC-
8
TURE.—In the case of any property described 
9
in subparagraph (A) that had been exported by 
10
the taxpayer for further manufacture, the in-
11
crease in cost or adjusted basis under subpara-
12
graph (A) shall not exceed the difference be-
13
tween the value of the property when exported 
14
and the value of the property when brought 
15
back into the United States after the further 
16
manufacture. 
17
‘‘(4) DOMESTIC MEDICAL AND DRUG MANUFAC-
18
TURING GROSS RECEIPTS.— 
19
‘‘(A) IN
GENERAL.—The term ‘domestic 
20
medical and drug manufacturing gross receipts’ 
21
means the gross receipts of the taxpayer which 
22
are derived from any sale, exchange, or other 
23
disposition of— 
24
03:03 Apr 08, 2022
H7410
6 
•HR 7410 IH
‘‘(i) any active pharmaceutical ingre-
1
dient, or 
2
‘‘(ii) any covered countermeasure, 
3
which was manufactured or produced by the 
4
taxpayer in whole or in significant part within 
5
the United States. 
6
‘‘(B) ACTIVE
PHARMACEUTICAL
INGRE-
7
DIENT.—The term ‘active pharmaceutical ingre-
8
dient’ means any substance or mixture of sub-
9
stances intended to be used in the manufacture 
10
of a drug product and (when so used) becomes 
11
an active ingredient in the drug product. 
12
‘‘(C) COVERED
COUNTERMEASURE.—The 
13
term ‘covered countermeasure’ has the meaning 
14
given such term in section 319F–3(i)(1) of the 
15
Public Health Service Act (42 U.S.C. 247d– 
16
6d(i)(1)). 
17
‘‘(D) PARTNERSHIPS
OWNED
BY
EX-
18
PANDED
AFFILIATED
GROUPS.—For purposes 
19
of this paragraph, if all of the interests in the 
20
capital and profits of a partnership are owned 
21
by members of a single expanded affiliated 
22
group at all times during the taxable year of 
23
such partnership, the partnership and all mem-
24
03:03 Apr 08, 2022
H7410
7 
•HR 7410 IH
bers of such group shall be treated as a single 
1
taxpayer during such period. 
2
‘‘(d) DEFINITIONS AND SPECIAL RULES.—For pur-
3
poses of this section— 
4
‘‘(1) APPLICATION OF SECTION TO PASS-THRU 
5
ENTITIES.— 
6
‘‘(A) PARTNERSHIPS
AND
S
CORPORA-
7
TIONS.—In the case of a partnership or S cor-
8
poration— 
9
‘‘(i) this section shall be applied at the 
10
partner or shareholder level, 
11
‘‘(ii) each partner or shareholder shall 
12
take into account such person’s allocable 
13
share of each item described in subpara-
14
graph (A) or (B) of subsection (c)(1) (de-
15
termined without regard to whether the 
16
items described in such subparagraph (A) 
17
exceed the items described in such sub-
18
paragraph (B)), and 
19
‘‘(iii) each partner or shareholder 
20
shall be treated for purposes of subsection 
21
(b) as having W–2 wages for the taxable 
22
year in an amount equal to such person’s 
23
allocable share of the W–2 wages of the 
24
partnership or S corporation for the tax-
25
03:03 Apr 08, 2022
H7410
8 
•HR 7410 IH
able year (as determined under regulations 
1
prescribed by the Secretary). 
2
‘‘(B) TRUSTS AND ESTATES.—In the case 
3
of a trust or estate— 
4
‘‘(i) the items referred to in subpara-
5
graph (A)(ii) (as determined therein) and 
6
the W–2 wages of the trust or estate for 
7
the taxable year, shall be apportioned be-
8
tween the beneficiaries and the fiduciary 
9
(and among the beneficiaries) under regu-
10
lations prescribed by the Secretary, and 
11
‘‘(ii) for purposes of paragraph (2), 
12
adjusted gross income of the trust or es-
13
tate shall be determined as provided in sec-
14
tion 67(e) with the adjustments described 
15
in such paragraph. 
16
‘‘(C) REGULATIONS.—The Secretary may 
17
prescribe rules requiring or restricting the allo-
18
cation of items and wages under this paragraph 
19
and may prescribe such reporting requirements 
20
as the Secretary determines appropriate. 
21
‘‘(2) APPLICATION
TO
INDIVIDUALS.—In the 
22
case of an individual, subsection (a)(2) shall be ap-
23
plied by substituting ‘adjusted gross income’ for 
24
‘taxable income’. For purposes of the preceding sen-
25
03:03 Apr 08, 2022
H7410
9 
•HR 7410 IH
tence, adjusted gross income shall be determined 
1
after application of sections 86, 135, 137, 219, 221, 
2
222, and 469. 
3
‘‘(3) 
SPECIAL
RULE
FOR
AFFILIATED 
4
GROUPS.— 
5
‘‘(A) IN GENERAL.—All members of an ex-
6
panded affiliated group shall be treated as a 
7
single corporation for purposes of this section. 
8
‘‘(B) EXPANDED
AFFILIATED
GROUP.— 
9
For purposes of this section, the term ‘ex-
10
panded affiliated group’ means an affiliated 
11
group as defined in section 1504(a), deter-
12
mined— 
13
‘‘(i) by substituting ‘more than 50 
14
percent’ for ‘at least 80 percent’ each place 
15
it appears, and 
16
‘‘(ii) without regard to paragraphs (2) 
17
and (4) of section 1504(b). 
18
‘‘(C) ALLOCATION OF CREDIT.—Except as 
19
provided in regulations, the credit under sub-
20
section (a) shall be allocated among the mem-
21
bers of the expanded affiliated group in propor-
22
tion to each member’s respective amount (if 
23
any) of qualified medical and drug manufac-
24
turing income. 
25
03:03 Apr 08, 2022
H7410
10 
•HR 7410 IH
‘‘(4) TRADE
OR
BUSINESS
REQUIREMENT.— 
1
This section shall be applied by only taking into ac-
2
count items which are attributable to the actual con-
3
duct of a trade or business. 
4
‘‘(5) COORDINATION WITH MINIMUM TAX.—For 
5
purposes of determining alternative minimum tax-
6
able income under section 55, qualified medical and 
7
drug manufacturing income shall be determined 
8
without regard to any adjustments under sections 56 
9
through 59. 
10
‘‘(6) UNRELATED
BUSINESS
TAXABLE
IN-
11
COME.—For purposes of determining the tax im-
12
posed by section 511, subsection (a)(1)(B) shall be 
13
applied by substituting ‘unrelated business taxable 
14
income’ for ‘taxable income’. 
15
‘‘(7) REGULATIONS.—The Secretary shall pre-
16
scribe such regulations as are necessary to carry out 
17
the purposes of this section, including regulations 
18
which prevent more than 1 taxpayer from being al-
19
lowed a credit under this section with respect to any 
20
activity described in subsection (c)(4)(A).’’. 
21
(b) TREATMENT UNDER BASE EROSION TAX.—Sec-
22
tion 59A(b)(1)(B)(ii) of such Code is amended by striking 
23
‘‘plus’’ at the end of subclause (I), by redesignating sub-
24
03:03 Apr 08, 2022
H7410
11 
•HR 7410 IH
clause (II) as subclause (III), and by inserting after sub-
1
clause (I) the following new subclause: 
2
‘‘(II) the credit allowed under 
3
section 38 for the taxable year which 
4
is properly allocable to the domestic 
5
medical and drug manufacturing cred-
6
it determined under section 45U(a), 
7
plus’’. 
8
(c) PART OF GENERAL BUSINESS CREDIT.—Section 
9
38(b) of such Code is amended by striking ‘‘plus’’ at the 
10
end of paragraph (32), by striking the period at the end 
11
of paragraph (33) and inserting ‘‘, plus’’, and by adding 
12
at the end the following new paragraph: 
13
‘‘(34) the domestic medical and drug manufac-
14
turing credit determined under section 45U(a).’’. 
15
(d) CREDIT ALLOWED AGAINST ALTERNATIVE MIN-
16
IMUM TAX.—Section 38(c)(4)(B) of such Code is amended 
17
by redesignating clauses (x) through (xii) as clauses (xi) 
18
through (xiii), respectively, and by inserting after clause 
19
(ix) the following new clause: 
20
‘‘(x) the credit determined under sec-
21
tion 45U,’’. 
22
(e) CLERICAL AMENDMENT.—The table of sections 
23
for subpart D of part IV of subchapter A of chapter 1 
24
03:03 Apr 08, 2022
H7410
12 
•HR 7410 IH
of such Code is amended by adding at the end the fol-
1
lowing new item: 
2
‘‘Sec. 45U. Domestic medical and drug manufacturing credit.’’. 
(f) EFFECTIVE DATE.—The amendments made by 
3
this section shall apply to taxable years beginning after 
4
December 31, 2021. 
5
SEC. 
3. 
QUALIFYING 
ADVANCED 
MEDICAL 
MANUFAC-
6
TURING EQUIPMENT CREDIT. 
7
(a) IN GENERAL.—Subpart E of part IV of sub-
8
chapter A of chapter 1 of the Internal Revenue Code of 
9
1986 is amended by adding at the end the following new 
10
section: 
11
‘‘SEC. 48D. QUALIFYING ADVANCED MEDICAL MANUFAC-
12
TURING EQUIPMENT CREDIT. 
13
‘‘(a) IN GENERAL.—For purposes of section 46, the 
14
qualifying advanced medical manufacturing equipment 
15
credit determined under this section for any taxable year 
16
is the applicable percentage of the basis of any qualifying 
17
advanced medical manufacturing equipment placed in 
18
service during such taxable year. 
19
‘‘(b) APPLICABLE PERCENTAGE.—For purposes of 
20
subsection (a), the applicable percentage is— 
21
‘‘(1) 30 percent in the case of equipment which 
22
is placed in service before January 1, 2029, 
23
‘‘(2) 20 percent in the case of equipment which 
24
is placed in service during calendar year 2029, 
25
03:03 Apr 08, 2022
H7410
13 
•HR 7410 IH
‘‘(3) 10 percent in the case of equipment which 
1
is placed in service during calendar year 2030, and 
2
‘‘(4) 0 percent in the case of equipment which 
3
is placed in service after December 31, 2030. 
4
‘‘(c) QUALIFYING ADVANCED MEDICAL MANUFAC-
5
TURING EQUIPMENT.—For purposes of this section, the 
6
term ‘qualifying advanced medical manufacturing equip-
7
ment’ means property— 
8
‘‘(1) which is machinery or equipment that is 
9
designed and used to manufacture a— 
10
‘‘(A) drug (as such term is defined in sec-
11
tion 201(g)(1) of the Federal Food, Drug, and 
12
Cosmetic Act), 
13
‘‘(B) device (as such term is defined in sec-
14
tion 201(h) of such Act), or 
15
‘‘(C) biological product (as such term is 
16
defined in section 351(i) of the Public Health 
17
Service Act), 
18
‘‘(2) which has been identified by the Secretary 
19
(after consultation with the Secretary of Health and 
20
Human Services) as machinery or equipment that— 
21
‘‘(A) incorporates novel technology or uses 
22
an established technique or technology in a new 
23
or innovative way, or 
24
03:03 Apr 08, 2022
H7410
14 
•HR 7410 IH
‘‘(B) that can improve medical product 
1
quality, address shortages of medicines, and 
2
speed time-to-market, 
3
‘‘(3) which is placed in service in the United 
4
States by the taxpayer, and 
5
‘‘(4) with respect to which depreciation is allow-
6
able. 
7
‘‘(d) CERTAIN
QUALIFIED
PROGRESS
EXPENDI-
8
TURES RULES MADE APPLICABLE.—Rules similar to the 
9
rules of subsections (c)(4) and (d) of section 46 (as in 
10
effect on the day before the enactment of the Revenue 
11
Reconciliation Act of 1990) shall apply for purposes of 
12
this section. 
13
‘‘(e) REGULATIONS.—The Secretary shall prescribe 
14
such regulations or other guidance as may be necessary 
15
to carry out the purposes of this section, including regula-
16
tions which prevent abuse or fraud.’’. 
17
(b) TREATMENT UNDER BASE EROSION TAX.—Sec-
18
tion 59A(b)(1)(B)(ii) of such Code, as amended under sec-
19
tion 1 of this Act, is further amended by striking ‘‘plus’’ 
20
at the end of subclause (II), by redesignating subclause 
21
(III) as subclause (IV), and by inserting after subclause 
22
(II) the following new subclause: 
23
‘‘(III) the credit allowed under 
24
section 46 for the taxable year which 
25
03:03 Apr 08, 2022
H7410
15 
•HR 7410 IH
is properly allocable to the qualifying 
1
advanced 
medical 
manufacturing 
2
equipment credit determined under 
3
section 48D(a), plus’’. 
4
(c) PART OF INVESTMENT CREDIT.—Section 46 of 
5
such Code is amended by striking ‘‘and’’ at the end of 
6
paragraph (5), by striking the period at the end of para-
7
graph (6) and inserting ‘‘, and’’, and by adding at the 
8
end the following new paragraph: 
9
‘‘(7) the qualifying advanced medical manufac-
10
turing equipment credit.’’. 
11
(d) CLERICAL AMENDMENT.—The table of sections 
12
for subpart D of part IV of subchapter A of chapter 1 
13
of such Code is amended by adding at the end the fol-
14
lowing new item: 
15
‘‘Sec. 48D. Qualifying advanced medical manufacturing equipment credit.’’. 
(e) EFFECTIVE DATE.—The amendments made by 
16
this section shall apply to periods after the date of the 
17
enactment of this section under rules similar to the rules 
18
of section 48(m) of the Internal Revenue Code of 1986 
19
(as in effect on the date of the enactment of the Revenue 
20
Reconciliation Act of 1990). 
21
SEC. 4. MEDICAL MANUFACTURING EPA COMPLIANCE 
22
CREDIT. 
23
(a) IN GENERAL.—Subpart E of part IV of sub-
24
chapter A of chapter 1 of the Internal Revenue Code of 
25
03:03 Apr 08, 2022
H7410
16 
•HR 7410 IH
1986, as amended by the preceding provisions of this Act, 
1
is amended by adding at the end the following new section: 
2
‘‘SEC. 48E. MEDICAL MANUFACTURING EPA COMPLIANCE 
3
CREDIT. 
4
‘‘(a) IN GENERAL.—For purposes of section 46, the 
5
medical manufacturing EPA compliance credit determined 
6
under this section for any taxable year is the applicable 
7
percentage of the basis of any qualifying medical manufac-
8
turing EPA compliance property placed in service during 
9
such taxable year. 
10
‘‘(b) APPLICABLE PERCENTAGE.—For purposes of 
11
subsection (a), the applicable percentage is— 
12
‘‘(1) 30 percent in the case of equipment which 
13
is placed in service before January 1, 2029, 
14
‘‘(2) 20 percent in the case of equipment which 
15
is placed in service during calendar year 2029, 
16
‘‘(3) 10 percent in the case of equipment which 
17
is placed in service during calendar year 2030, and 
18
‘‘(4) 0 percent in the case of equipment which 
19
is placed in service after December 31, 2030. 
20
‘‘(c) QUALIFYING MEDICAL MANUFACTURING EPA 
21
COMPLIANCE PROPERTY.—For purposes of this section, 
22
the term ‘qualifying medical manufacturing EPA compli-
23
ance equipment’ means property— 
24
03:03 Apr 08, 2022
H7410
17 
•HR 7410 IH
‘‘(1) which is used by the taxpayer in the trade 
1
or business of manufacturing a— 
2
‘‘(A) drug (as such term is defined in sec-
3
tion 201(g)(1) of the Federal Food, Drug, and 
4
Cosmetic Act), 
5
‘‘(B) device (as such term is defined in sec-
6
tion 201(h) of such Act), 
7
‘‘(C) biological product (as such term is 
8
defined in section 351(i) of the Public Health 
9
Service Act), or 
10
‘‘(D) active pharmaceutical ingredient or 
11
covered countermeasure (within the meaning of 
12
section 45U(c)(4)), 
13
‘‘(2) which is used to meet emissions limits 
14
under the Clean Air Act or wastewater standards 
15
under the Clean Water Act, 
16
‘‘(3) which is placed in service in the United 
17
States by the taxpayer, 
18
‘‘(4) with respect to which depreciation is allow-
19
able, and 
20
‘‘(5) which is not qualifying advanced medical 
21
manufacturing equipment (as defined in section 
22
48D). 
23
‘‘(d) CERTAIN
QUALIFIED
PROGRESS
EXPENDI-
24
TURES RULES MADE APPLICABLE.—Rules similar to the 
25
03:03 Apr 08, 2022
H7410
18 
•HR 7410 IH
rules of subsections (c)(4) and (d) of section 46 (as in 
1
effect on the day before the enactment of the Revenue 
2
Reconciliation Act of 1990) shall apply for purposes of 
3
this section. 
4
‘‘(e) REGULATIONS.—The Secretary shall prescribe 
5
such regulations or other guidance as may be necessary 
6
to carry out the purposes of this section, including regula-
7
tions which prevent abuse or fraud.’’. 
8
(b) TREATMENT UNDER BASE EROSION TAX.—Sec-
9
tion 59A(b)(1)(B)(ii) of such Code, as amended by the 
10
preceding provisions of this Act, is further amended by 
11
striking ‘‘plus’’ at the end of subclause (III), by redesig-
12
nating subclause (IV) as subclause (V), and by inserting 
13
after subclause (III) the following new subclause: 
14
‘‘(IV) the credit allowed under 
15
section 46 for the taxable year which 
16
is properly allocable to the medical 
17
manufacturing EPA compliance credit 
18
determined under section 48E(a), 
19
plus’’. 
20
(c) PART OF INVESTMENT CREDIT.—Section 46 of 
21
such Code, as amended by the preceding provisions of this 
22
Act, is amended by striking ‘‘and’’ at the end of paragraph 
23
(6), by striking the period at the end of paragraph (7) 
24
03:03 Apr 08, 2022
H7410
19 
•HR 7410 IH
and inserting ‘‘, and’’, and by adding at the end the fol-
1
lowing new paragraph: 
2
‘‘(8) the medical manufacturing EPA compli-
3
ance credit.’’. 
4
(d) CLERICAL AMENDMENT.—The table of sections 
5
for subpart D of part IV of subchapter A of chapter 1 
6
of such Code, as amended by the preceding provisions of 
7
this Act, is amended by adding at the end the following 
8
new item: 
9
‘‘Sec. 48E. Medical manufacturing EPA compliance credit.’’. 
(e) EFFECTIVE DATE.—The amendments made by 
10
this section shall apply to periods after the date of the 
11
enactment of this section under rules similar to the rules 
12
of section 48(m) of the Internal Revenue Code of 1986 
13
(as in effect on the date of the enactment of the Revenue 
14
Reconciliation Act of 1990). 
15
Æ 
03:03 Apr 08, 2022
H7410
